BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7023823)

  • 1. Self-administration of prostaglandin for termination of early pregnancy.
    Bygdeman M; Christensen NJ; Gréen K; Zheng S
    Contraception; 1981 Jul; 24(1):45-52. PubMed ID: 7023823
    [No Abstract]   [Full Text] [Related]  

  • 2. Termination of early gestation with 9-deoxo-16,16-dimethyl-9-methylene prostaglandin E2.
    Brenner PF; Marrs RP; Roy S; Mishell DR
    Contraception; 1982 Sep; 26(3):261-77. PubMed ID: 6184197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Termination of early pregnancy through a combination of the antiprogestin and prostaglandin analogue.
    Maria B; Stampf F; Goepp A; Dubois C
    Eur J Obstet Gynecol Reprod Biol; 1990 Oct; 37(1):35-40. PubMed ID: 2376278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of 16-16 dimethyl trans delta 2 PGE1 methyl ester (ONO 802) vaginal suppositories for the termination of early pregnancy. A comparative study.
    Smith SK; Baird DT
    Br J Obstet Gynaecol; 1980 Aug; 87(8):712-7. PubMed ID: 7426533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mid-trimester abortion by vaginal administration of 9-deoxo-16, 16-dimethyl-9-methylene-PGE2.
    Bygdeman M; Christensen N; Gréen K; Lundström V
    Contraception; 1980 Aug; 22(2):153-64. PubMed ID: 7449380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of two stable prostaglandin E analogues for termination of early pregnancy and for cervical dilatation.
    Bygdeman M; Bremme K; Christensen N; Lundström V; Gréen K
    Contraception; 1980 Nov; 22(5):471-83. PubMed ID: 7471738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Termination of early pregnancy. Future development.
    Bygdeman M; Christensen NJ; Gréen K; Zheng S; Lundström V
    Acta Obstet Gynecol Scand Suppl; 1983; 113():125-9. PubMed ID: 6574667
    [No Abstract]   [Full Text] [Related]  

  • 8. Low-dose prostaglandin E2 analogue for cervical dilatation prior to pregnancy termination.
    Borten M; DiLeo LA; Friedman EA
    Am J Obstet Gynecol; 1984 Nov; 150(5 Pt 1):561-5. PubMed ID: 6496588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The vaginal administration of 9-deoxo-16,16-dimethyl-9-methylene PGE2 for second trimester abortion.
    Ballard CA
    Contraception; 1981 Aug; 24(2):151-7. PubMed ID: 7297067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravaginal administration of 9-deoxo-9-methylene-16,16-dimethyl PGE2 for cervical dilation prior to suction curettage.
    Shapiro AG; Lasseter K; Cobiella A; Domenzain M
    Int J Gynaecol Obstet; 1982 Apr; 20(2):137-40. PubMed ID: 6125434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cervical dilatation with meteneprost vaginal suppositories in first trimester abortion.
    Somell C; Olund A
    Contraception; 1986 Feb; 33(2):189-94. PubMed ID: 3698595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interruption of pregnancy with vaginal suppositories containing 16,16-dimethyl-trans-delta 2-prostaglandin E1 methyl ester.
    Wagatsuma T; Tabuchi T; Tabei T; Kaku R
    Contraception; 1979 Jun; 19(6):591-7. PubMed ID: 487809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abortifacient effect and uterine cervix-dilating action of 16, 16-dimethyl trans delta 2 PGE1 methyl ester (ONO 802) in the form of a vaginal suppository (a randomized, double-blind, controlled study in the second trimester of pregnancy).
    Sakamoto S; Satoh K; Nishiya I; Kunimoto K; Chimura T; Oda T; Takeuchi S; Satoh Y; Iizuka R; Kobayashi T; Takagi S; Yoshida T; Tomoda Y; Ninagawa T; Kurachi K; Tanizawa O; Tojo S; Mochizuki M; Maeda K; Tominaga Y; Torigoe T; Koresawa M; Taki I; Hamada T
    Prostaglandins Leukot Med; 1982 Sep; 9(3):349-61. PubMed ID: 6752961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study of various intracervically administered PG gel preparations for termination of first trimester pregnancies.
    Rath W; Meyer D; Hildebrandt J; Hilgers R; Kuhn W
    Contraception; 1983 Sep; 28(3):209-22. PubMed ID: 6357631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Termination of early pregnancy by a single-dose 3.0 mg 15-methyl PGF2alpha methyl ester vaginal suppository.
    Mandelin M
    Prostaglandins; 1978 Jul; 16(1):143-52. PubMed ID: 704921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostaglandin vaginal suppositories in non pregnant women requiring cervical dilatation prior to hysteroscopy.
    Hald F; Kristoffersen SE; Gregersen E
    Acta Obstet Gynecol Scand; 1988; 67(3):219-22. PubMed ID: 3051874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HCG, progesterone and 17-beta-estradiol levels during extra-amniotically induced early abortion by a new prostaglandin derivative (Sulprostone).
    Nilsson S; Zador G; Nygren KG; Wide L
    Gynecol Obstet Invest; 1981; 12(4):203-10. PubMed ID: 7250783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Termination of very early pregnancy by vaginal suppositories-(15S)-15-methyl prostaglandin F2 alpha methyl ester.
    Wan LS; Stiber AJ; Turkel J
    Contraception; 1981 Dec; 24(6):603-15. PubMed ID: 6173156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early pregnancy-abortion model using sulprostone.
    Fleischer A; Schulman H; Blattner P; Jagani N; Fayemi A
    Prostaglandins; 1982 May; 23(5):643-55. PubMed ID: 7122906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pregnancy termination: techniques, risks, and complications and their management.
    Castadot RG
    Fertil Steril; 1986 Jan; 45(1):5-17. PubMed ID: 3510916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.